Search

everythinglearnresearchcommunity

for

Search:↓

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

The conclusion is that different blood diseases cause specific oral symptoms and require varied treatments to manage these symptoms and improve patient health.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

A positive anagen pull test can help detect active Lichen Planopilaris.

A woman with rheumatoid arthritis had a unique type of scarring hair loss not caused by infection, requiring early treatment to avoid permanent hair loss.

An infant with a zinc deficiency skin disorder improved with zinc treatment.

The new gel for psoriasis is effective, stable, and easy to apply.

Topical diphencyprone effectively treated a 9-year-old boy's alopecia areata with fewer side effects.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

A patient with a skin condition had unusual scarring hair loss but improved with treatment.

The document is a detailed medical reference on skin and genetic disorders.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

Both atopy and eosinophilia are linked to more severe hair loss in people with alopecia areata.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

A heart transplant patient developed a skin condition called epidermodysplasia verruciformis after taking immune-suppressing drugs.

Low-dose isotretinoin is as effective as conventional doses for acne and has fewer side effects.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

Lactic acid cream can help improve skin bumps known as eruptive vellus hair cysts.

Mnemonics with one letter are useful and easy to remember for learning dermatology.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Genes controlling hair growth and immune response are disrupted in male pattern baldness.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Stress-related substance P may lead to hair loss and negatively affect hair growth.